B12 deficiency is typically characterised by symptoms such as extreme tiredness, lack of energy, muscle weakness, and even problems with memory
Its used to treat and prevent Vitamin B12 deficiency , pernicious anemia , neurological disorders , and cyanide poisoning
Archived from the original on January 25, 2017
In a systematic review and meta-analysis on the safety and efficacy of DOACs and warfarin in elderly patients with atrial fibrillation, researchers concluded that there were no significant differences in the DOACs studied (rivaroxaban, dabigatran, apixaban, and edoxaban) in terms of stroke or blood clot prevention
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
Doctors decide if someone needs B12 shots based on their health and how much B12 they have